KMAP BULLETIN: Pharmacist as Provider – Billable Services – Medication Administration

Date: 12/17/25

KMAP GENERAL BULLETIN 25289 (PDF)

Effective dates of service on or after January 1, 2026, pharmacists enrolled under provider type and specialty 32/276 will be allowed to administer select injectable medications listed below.

Medications Approved to Administer (including generic versions):

• Long-Acting Injectable Antipsychotics
  • Abilify Maintena® (aripiprazole extended release)
  • Aristada® (aripiprazole lauroxil extended release) (441mg only)
  • Aristada Initio® (aripiprazole lauroxil extended release)
  • Invega Sustenna® (paliperidone palmitate extended release)
  • Invega Trinza® (paliperidone palmitate extended release)
  • Perseris® (risperidone extended release)
  • Prolixin® (Fluphenazine Decanoate)
  • Risperdal® Consta® (risperidone long acting)
  • Uzedy (risperidone extended release)
• Contraceptives
  • Depo-Provera® (Medroxyprogesterone acetate)
  • Depo-SubQ Provera 104® (Medroxyprogesterone acetate)

Billing Guidelines:

• The administration fee is to be billed on the medical benefit, using the administration code of 96372.
  • The National Drug Code (NDC) loop for the administrated drug must be populated on the claim.
• The drug is to be billed through the point of sale (POS) pharmacy benefit.
• A Point-of-Sale claim for the select injectable medication administered must be billed for the member within seven calendar days of the service code billing.

The enrollment requirements and billing guidelines for Pharmacists remain the same as published on Updated Bulletin 23196. The performing (rendering) provider must be pharmacist National Provider Identifier (NPI) (32/276), and the billing provider must be pharmacy NPI (32/240).

Billing Guidelines for NDC Submission:

Refer to the guidelines below for accurate billing of NDC information for the administered drug. 

837P Electronic	CMS-1500 Paper
Detail Level: (must be billed with the same line number as the administration code 96372) NDC Qualifier: 2410 LIN02 (valid qualifier value: N4) NDC: 2410 LIN03 Drug Quantity: 2410 CTP04 Drug UOM: 2410 CTP05 Example: LIN**N4*11111111111 CTP****5*UN *Code 11111111111 is invalid and used for illustrative purposes only.	Refer to the CMS-1500 Paper Form instructions on KMAP Public page. Field 24 – Enter in the shaded areas (top portion) of the numbered rows, as appropriate with the line number associated with the administration code. The NDC information can be entered as follows in the single line sequence. NDC||Description||UOM||Quantity

 

Note: The effective date of the policy is January 1, 2026. The implementation of State policy by the KanCare Managed Care Organizations (MCOs) may vary from the date noted in the Kansas Medical Assistance Program (KMAP) bulletins. The KanCare Open Claims Resolution Log on the KMAP Bulletins page documents the MCO system status for policy implementation and any associated reprocessing completion dates once the policy is implemented.

For changes resulting from this bulletin, view the updated Pharmacy Fee-for-Service Provider Manual, page 8-10 and Professional Fee-for-Service Provider Manual, page 8-66.